Shandong Linuo Pharmaceutical Packaging Co., Ltd. (SHE:301188)
China · Delayed Price · Currency is CNY 36.69
-0.77 (-2.06%)
Aug 25, 2026, 1:45 PM CST
SHE:301188 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 9,719 | 4,095 | 3,438 | 4,158 | 3,165 | 5,717 | |
Market Cap Growth | 112.13% | 19.08% | -17.30% | 31.35% | -44.63% | - |
Enterprise Value | 9,642 | 4,035 | 3,096 | 3,600 | 2,643 | 5,682 |
Last Close Price | 37.46 | 17.57 | 14.92 | 17.66 | 13.30 | 23.74 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 325.60 | 103.24 | 52.05 | 63.08 | 27.14 | 45.82 |
Forward PE | 96.05 | 29.25 | 20.47 | 34.57 | 20.79 | - |
PS Ratio | 8.41 | 4.17 | 3.18 | 4.39 | 3.85 | 6.43 |
PB Ratio | 4.97 | 2.60 | 2.21 | 2.67 | 2.21 | 4.20 |
P/TBV Ratio | 5.16 | 2.73 | 2.32 | 2.71 | 2.26 | 4.29 |
P/OCF Ratio | - | - | 27.95 | 67.73 | 68.24 | 108.97 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 8.34 | 4.11 | 2.86 | 3.80 | 3.22 | 6.39 |
EV/EBITDA Ratio | 50.36 | 22.45 | 17.35 | 25.80 | 16.59 | 31.11 |
EV/EBIT Ratio | 181.19 | 75.31 | 42.65 | 63.21 | 28.12 | 44.56 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.18 | 0.40 | 0.27 | 0.24 | 0.00 | 0.02 |
Debt / EBITDA Ratio | 1.87 | 3.49 | 2.30 | 2.67 | 0.01 | 0.14 |
Net Debt / Equity Ratio | -0.04 | 0.03 | -0.24 | -0.34 | -0.37 | -0.50 |
Net Debt / EBITDA Ratio | -0.41 | 0.28 | -2.10 | -3.78 | -3.33 | -3.75 |
Net Debt / FCF Ratio | 0.18 | -0.16 | 4.33 | 10.14 | 4.57 | 32.72 |
Asset Turnover | 0.43 | 0.39 | 0.48 | 0.50 | 0.51 | 0.78 |
Inventory Turnover | 2.11 | 2.14 | 3.71 | 4.26 | 4.56 | 6.12 |
Quick Ratio | 1.34 | 1.93 | 3.17 | 5.94 | 3.81 | 4.64 |
Current Ratio | 2.36 | 3.08 | 4.09 | 7.07 | 4.77 | 5.37 |
Return on Equity (ROE) | 1.68% | 2.54% | 4.24% | 4.41% | 8.36% | 13.05% |
Return on Assets (ROA) | 1.24% | 1.32% | 2.01% | 1.88% | 3.67% | 7.02% |
Return on Invested Capital (ROIC) | 2.01% | 3.08% | 6.07% | 5.33% | 10.97% | 18.82% |
Return on Capital Employed (ROCE) | 2.40% | 2.40% | 3.60% | 2.90% | 6.50% | 9.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 0.31% | 0.97% | 1.92% | 1.58% | 3.69% | 2.18% |
FCF Yield | -4.55% | -7.49% | -2.52% | -1.25% | -3.66% | -0.37% |
Dividend Yield | 0.26% | 0.57% | 0.67% | 0.57% | 1.50% | 0.84% |
Payout Ratio | 110.62% | 67.68% | 37.05% | 70.52% | 39.96% | 1.17% |
Buyback Yield / Dilution | -10.78% | -2.40% | 3.23% | -0.91% | -30.88% | -2.08% |
Total Shareholder Return | -10.52% | -1.84% | 3.90% | -0.34% | -29.38% | -1.24% |